Nathalie Brouard

ORCID: 0000-0003-0727-9377
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hematopoietic Stem Cell Transplantation
  • Mesenchymal stem cell research
  • Platelet Disorders and Treatments
  • Neonatal Respiratory Health Research
  • Virus-based gene therapy research
  • Immunotherapy and Immune Responses
  • Glycosylation and Glycoproteins Research
  • Pancreatic function and diabetes
  • Cancer Cells and Metastasis
  • Immune Cell Function and Interaction
  • Cell Adhesion Molecules Research
  • Blood groups and transfusion
  • Tissue Engineering and Regenerative Medicine
  • T-cell and Retrovirus Studies
  • Blood transfusion and management
  • T-cell and B-cell Immunology
  • Fibroblast Growth Factor Research
  • Immune Response and Inflammation
  • Chemokine receptors and signaling
  • Pluripotent Stem Cells Research
  • RNA Interference and Gene Delivery
  • Erythrocyte Function and Pathophysiology
  • Sexual function and dysfunction studies
  • Inflammatory Biomarkers in Disease Prognosis
  • Blood donation and transfusion practices

Inserm
2013-2025

Établissement Français du Sang
2016-2025

Université de Strasbourg
2013-2023

Laboratoire de Neurosciences Cognitives et Adaptatives
2023

Brown Foundation
2007-2017

The University of Texas Health Science Center at Houston
2009-2012

Peter MacCallum Cancer Centre
2001-2010

Institute for Molecular Medicine
2007

Institut de Radioprotection et de Sûreté Nucléaire
1998-2000

Institut Jacques Monod
1997

The cellular and molecular microenvironment of epithelial stem progenitor cells is poorly characterized despite well-documented roles in homeostatic tissue renewal, wound healing, cancer progression. Here, we demonstrate that, organotypic cocultures, dermal pericytes substantially enhanced the intrinsically low tissue-regenerative capacity human epidermal that have committed to differentiate this enhancement was independent angiogenesis. We used microarray analysis identify genes expressed...

10.1172/jci38535 article EN Journal of Clinical Investigation 2009-08-03

Originally identified as a marker specifying murine hematopoietic stem cells, the Sca-1 antigen has since been shown to be differentially expressed by candidate cells in tissues including vascular endothelium, skeletal muscle, mammary gland, and prostate of adult mice. In lung, previously selectable for isolation nonhematopoietic (CD45(-)), nonendothelial (CD31(-)) bronchioalveolar (BASC) located at duct junction that coexpress surfactant protein C Clara cell specific protein. Our systematic...

10.1634/stemcells.2008-0866 article EN Stem Cells 2008-12-13

Germ line or hypothalamus-specific deletion of Y2 receptors in mice results a doubling trabecular bone volume. However, the specific mechanism by which increases mass has not yet been identified. Here we show that cultured adherent marrow stromal cells from <i>Y2</i><sup>-/-</sup> also demonstrate increased mineralization <i>in vitro</i>. Isolation two populations progenitor cell types, an immature mesenchymal stem population and more highly differentiated cells, revealed greater number...

10.1074/jbc.m609629200 article EN cc-by Journal of Biological Chemistry 2007-05-10

Microenvironment and activation signals likely imprint heterogeneity in the lymphatic endothelial cell (LEC) population. Particularly LECs of secondary lymphoid organs are exposed to different types immune stimuli. However, our understanding nature LEC their source within organ steady state remains incomplete. Here we show that integrin alpha 2b (ITGA2b), known be carried by platelets, megakaryocytes hematopoietic progenitors, is expressed a lymph node subset LECs, residing medullary,...

10.1371/journal.pone.0151848 article EN cc-by PLoS ONE 2016-03-24

In hematopoiesis, co-expression of Sca-1 and c-Kit defines cells (LS(+)K) with long term reconstituting potential. contrast, poorly characterized LS(-)K fail to reconstitute lethally irradiated recipients. Relative quantification mass spectrometry transcriptional profiling were used characterize LS(+)K cells. This approach yielded data on >1200 proteins. Only 32% protein changes correlated mRNA modulation demonstrating post-translational regulation in early hematopoietic development. had...

10.1074/mcp.m700292-mcp200 article EN cc-by Molecular & Cellular Proteomics 2007-12-16

Megakaryocytes (MKs) are the precursor cells of platelets, located in bone marrow (BM). Once mature, they extend elongated projections named proplatelets through sinusoid vessels, emerging from stroma into circulating blood. Not all signals microenvironment that regulate proplatelet formation understood, particularly those BM biomechanics. We sought to investigate how MKs perceive and adapt modifications stiffness their environment. Although is one softest tissue body, its rigidification...

10.1182/bloodadvances.2022008680 article EN cc-by-nc-nd Blood Advances 2023-05-12

Abstract The use of umbilical cord blood (UCB) grafts for hematopoietic stem cell transplantation (HSCT) is a promising technique that permits degree human leukocyte antigen mismatch between the graft and host without concomitant higher rate graft-versus-host disease would be observed an adult marrow mismatched host. A disadvantage to UCB HSCT immune reconstitution may significantly delayed because low dose available in graft. Ex vivo expansion CD34 cells provide greater number cells;...

10.1002/stem.111 article EN Stem Cells 2009-04-30

The fetal liver is the site of a major expansion hematopoietic stem cell (HSC) pool and also privileged organ to study megakaryocyte progenitor differentiation. We identified in mouse at day 13.5 discrete stromal population harboring CD45-TER119-CD31-CD51+VCAM-1+PDGFRα- (V+P-) phenotype that lacked colony-forming unit fibroblast activity harbored an hepatocyte signature. This previously undescribed V+P- efficiently supported production from bone marrow HSC human peripheral blood HSC-myeloid...

10.1182/bloodadvances.2016003541 article EN cc-by-nc-nd Blood Advances 2017-09-26

Transplantation of BM stromal cells engineered to secrete therapeutic factors could represent a treatment for large array hematologic disorders. The aim this study was evaluate the susceptibility human cell precursors retroviral gene transfer, then ability those be transplanted in vivo. We have transduced recombinant retrovirus encoding mouse CD2 antigen into STRO-1+ selected from adult and fetal BM. Gene-modified were injected intravenously NOD-SCID mice engrafted previously with pieces...

10.1089/152581600319388 article EN Journal of Hematotherapy & Stem Cell Research 2000-04-01

Ex vivo expanded CD34+ progenitor cells from fresh or cryopreserved primate bone marrow, induced to granulocytic differentiation with growth factors, were investigated determine whether myeloid produced in liquid cultures have the normal biologic functions needed for treatment of patients neutropenia following high-dose chemotherapy therapeutic accidental radiation exposure. Human and simian (baboons macaques) cultured granulocyte-colony stimulating factor (G-CSF), stem cell (SCF),...

10.1089/scd.1.1998.7.69 article EN Journal of Hematotherapy 1998-02-01

CD34(+) cell dose provides a measure of hematopoietic tissue that predicts the rate engraftment upon transplant. It is positively correlated with multiple measures recovery, including platelet engraftment. Here we identify subpopulation cells coexpress surface antigen--MA6, which more in clinical setting than alone. The specific identity and function MA6 remain to be determined, however, it expressed by primitive megakaryocyte (MK) progenitors, but lost differentiation not platelets....

10.1089/scd.2014.0439 article EN Stem Cells and Development 2015-02-12
Coming Soon ...